Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy (PROSTED)

Centre Hospitalier Universitaire de Nīmes

Status: Enrolling

Conditions: Prostate Cancer

Treatments: Other: Workshop; Other: Focus group creation

Study type: Observational

Funder types: Other

Identifiers

NCT04048252

LOCAL/2019/NH-02

Details and patient eligibility

About

The development of a personalized therapeutic education program dedicated to patients with metastatic prostate cancer and receiving next-generation hormone therapy would improve their knowledge of the disease, medication adherence and quality of life.

Enrollment: 18 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with metastatic prostate cancer treated with enzalutamide or abiraterone acetate for at least 3 months
• The patient must have given their free and informed consent and signed the consent form
• The patient must be insured or the beneficiary of an insurance policy

Exclusion criteria

• The subject is not in a fit state to express their consent
• It is impossible to give the subject informed information
• The patient is under safeguard of justice or state guardianship

Trial design

18 participants in 2 patient groups

Focus group

Treatment:

Other: Focus group creation

Workshop

Treatment:

Other: Workshop